IRAK4 and rheumatoid arthritis: Our studies have shown that the onset of rheumatoid arthritis (RA) is abrogated by the inhibition of IRAK4 in TLR7-induced inflammation in macrophage and fibroblast cell-based and in vivo models of joint inflammation (30–32).